Ampersand Biosciences LLC
Lake Clear, NY
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 6459 NY-30, Lake Clear, NY 12945, USA
- Website
- ampersandbio.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $599,987 |
| FY2024 | $1,084,824 |
| FY2023 | -$9,840 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Ampersand Biosciences LLC is a woman-owned small business biotechnology research company located in Lake Clear, New York, specializing in immunological research and development of advanced scientific reagents. Registered in SAM.gov since December 2014 with active registration until April 2026, the company operates as a limited liability partnership and focuses on developing innovative solutions for understanding and potentially preventing infectious diseases. The firm has established itself as a focused research entity with expertise in immunological studies, particularly in respiratory disease models.
The company has secured multiple federal contract awards from the National Institute of Allergy and Infectious Diseases (NIAID), totaling approximately $2.28 million across three recent contracts. These contracts consistently center on developing monoclonal antibodies and immunological research reagents, with specific focus on respiratory disease models involving non-traditional research subjects like ferrets and mice. The contract awards, ranging from $596,519 to $1,084,824, have supported projects such as developing monoclonal antibodies to chemokines, characterizing and validating antibodies for respiratory disease research, and creating reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models. None of these contracts were set-aside, and they all represent definitive, firm fixed-price agreements with completion dates ranging from December 2024 to May 2027, demonstrating Ampersand Biosciences' ongoing commitment to advanced infectious disease research.
Quick answers
Is Ampersand Biosciences LLC registered in SAM.gov?
Yes. Ampersand Biosciences LLC's SAM.gov registration is active through February 17, 2027.
What is Ampersand Biosciences LLC's CAGE code?
Ampersand Biosciences LLC's CAGE code is 79VC0, and its Unique Entity ID (UEI) is HLWQXLFM7JR8.
How much has Ampersand Biosciences LLC received in federal contracts?
Federal contracts obligated $599,987 to Ampersand Biosciences LLC in fiscal year 2025 and $1,674,971 in fiscal years 2023 through 2027.
How does Ampersand Biosciences LLC rank among federal contractors?
Ampersand Biosciences LLC ranked #84 in PSC AN11 in FY2025.
What is Ampersand Biosciences LLC's most recent federal award?
Ampersand Biosciences LLC's most recent federal contract award is Definitive Contract 75N93025C00018, from National Institute of Allergy and Infectious Diseases (NIH), on June 1, 2025.
On GovTribe
See Ampersand Biosciences LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors